Fat-free mass loss

There are 2 papers on fat-free mass loss in aging research: 1 trial and 1 observational study in people.

Biomarker

2 papers study it12 more mention it3 findings

See all 14 papers on fat-free mass loss

“less loss of fat-free mass and greater IGF-1 levels were associated with reduced mortality during the next 2 years”
Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart StudyThe American journal of medicine2003doi:10.1016/j.amjmed.2003.05.001
  • Human trial1
  • Humans1

Interventions

2

2'-fucosyllactose

downin humans1

1 study
  1. 2'-fucosyllactose decreases fat-free mass loss in humans with exercise and caloric restriction (−229 g vs −983 g).

    “Additionally, there was evidence suggesting that the 2′-FL group was more successful in maintaining the fat-free mass (2′-FL: −229 g [−1250, 791], p = 0.652; PLA: −983 g [−2029, 63], p = 0.065).”

    Human trialwith exercise and caloric restriction12 weeksn = 41

    Effects of Human Milk Oligosaccharide 2'-Fucosyllactose Ingestion on Weight Loss and Markers of Health

    Nutrients

More on 2'-fucosyllactose

Intermittent energy restriction

downin humans1

1 study
  1. Intermittent energy restriction prevents fat-free mass loss in humans (carbohydrate refeed versus continuous energy restriction in resistance-trained individuals) (FFM change RF Δ0.4 kg vs CN Δ1.3 kg).

    “A 2-day carbohydrate refeed preserves FFM, dryFFM, and RMR during energy restriction compared to continuous energy restriction in RT-individuals.”

    Human trialcarbohydrate refeed versus continuous energy restriction in resistance-trained individualstwo consecutive days of elevated carbohydrate intake each week~25% caloric restriction7 weeksn = 27

    Intermittent Energy Restriction Attenuates the Loss of Fat Free Mass in Resistance Trained Individuals. A Randomized Controlled Trial

    Journal of functional morphology and kinesiology

More on Intermittent energy restriction

Associations

1

Mortality

upin humans1

1 study
  1. Fat-free mass loss is linked with a higher risk of mortality in humans (change in fat-free mass index over first 2 years; subset with 55 deaths).

    “less loss of fat-free mass and greater IGF-1 levels were associated with reduced mortality during the next 2 years”

    Humanschange in fat-free mass index over first 2 years; subset with 55 deaths2 years of change, 2 years of follow-upn = 398

    Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study

    The American journal of medicine

Latest

Dec 2025: 1Jan 2026: 2Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 1Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 1Nov 2026: 05 papers in 12 months

See all 14 papers on fat-free mass loss